SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Aurora Spine Corporation (ASAPF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 31/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ASAPF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.89
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.01
Book Value / Share$0.00
Revenue / Share$0.22
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-0.11 |
$4.9M |
$-2.92M |
-59.5% |
| 2016 |
$-0.05 |
$6.76M |
$-1.68M |
-24.9% |
| 2017 |
$-0.06 |
$5.99M |
$-2.16M |
-36% |
| 2018 |
$0.00 |
$8.68M |
$-80.25K |
-0.9% |
| 2019 |
$-0.03 |
$11.15M |
$-1.43M |
-12.8% |
| 2020 |
$-0.01 |
$8.65M |
$-319.8K |
-3.7% |
| 2021 |
$-0.04 |
$10.54M |
$-2.52M |
-23.9% |
| 2022 |
$-0.02 |
$14.88M |
$-1.56M |
-10.5% |
| 2023 |
$-0.02 |
$14.52M |
$-1.68M |
-11.6% |
| 2024 |
$-0.01 |
$16.72M |
$-954.47K |
-5.7% |
